Cancer Topics – Beyond Adjuvant Chemotherapy: Precision Oncology in Early-stage NSCLC
Adjuvant immunotherapy is a game-changer for early lung cancer, but it is not the best choice for every patient. Through patient cases, Drs. Karen Kelly (University of California Davis) and Howard West (City of Hope Cancer Center) explore considerations in shared decision making and personalizing therapy.
Subscribe: Apple Podcasts, Google Podcasts | Additional resources: education.asco.org | Contact Us
Air Date: 12/15/21
Create your
podcast in
minutes
It is Free